Shankar Balasubramanian awarded Breakthrough Prize
Prof Sir Shankar Balasubramanian, Senior Group Leader, has been awarded the 2022 Breakthrough Prize in Life Sciences – the world’s largest science prize – for the development of next-generation DNA sequencing. He shares the award with Prof Sir David Klenerman, Department of Chemistry, and Pascal Mayer, from the French company Alphanosos.
Professors Balasubramanian and Klenerman co-invented Solexa-Illumina Next Generation DNA Sequencing (NGS), technology that has enhanced our basic understanding of life, converting biosciences into ‘big science’ by enabling fast, accurate, low-cost and large-scale genome sequencing – the process of determining the complete DNA sequence of an organism’s make-up. They co-founded the company Solexa to make the technology available to the world.
The benefits to society of rapid genome sequencing are huge. The almost immediate identification and characterisation of the virus which causes COVID-19, rapid development of vaccines, and real-time monitoring of new genetic variants would have been impossible without the technique Balasubramanian and Klenerman developed.
The technology has had – and continues to have – a transformative impact in the fields of genomics, medicine and biology. One measure of the scale of change is that it has allowed a million-fold improvement in speed and cost when compared to the first sequencing of the human genome. In 2000, sequencing of one human genome took over 10 years and cost more than a billion dollars: today, the human genome can be sequenced in a single day at a cost of less than $1,000. More than a million human genomes are sequenced at scale each year, thanks to the technology co-invented by Professors Balasubramanian and Klenerman, meaning we can understand diseases much better and much more quickly. Earlier this year, they were awarded the Millennium Technology Prize.
For the tenth year, the Breakthrough Prize recognises the world’s top scientists. Each prize is US $3 million and presented in the fields of Life Sciences, Fundamental Physics (one per year) and Mathematics (one per year). In addition, up to three New Horizons in Physics Prizes, up to three New Horizons in Mathematics Prizes and up to three Maryam Mirzakhani New Frontiers Prizes are given out to early-career researchers each year, each worth US $100,000. The Breakthrough Prizes were founded by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Yuri and Julia Milner, and Anne Wojcicki.
Related News
See all news-
Scientists to Shine a Light on Cancer Research at Inspirational Night Walk
10th October 2025
Dr Shalini Rao, a Senior Research Associate at the Cancer Research UK Cambridge Institute, will join postgraduate students Marleen Wolke and Josephine Greenall-Ota for the Shine Night Walk on Saturday, 18 October.
Find out more -
Prof Greg Hannon shortlisted for prestigious Cancer Grand Challenge
24th September 2025
The shortlist of 12 multidisciplinary, global teams is now competing for up to £20m each, with the aim of delivering breakthroughs that no single researcher, lab, institute or country could achieve alone.
Find out more -
Future scientists join our second Cambridge LaunchPad project day
18th August 2025
Students from Thomas Clarkson Academy in Wisbech joined us for a unique opportunity to experience the world of cancer research first-hand.
Find out more